Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/7/2025

Management of Anger and Aggression

Introduction to Treatment

  • Medication should not be the sole intervention for anger management, and cognitive behavioral therapy (CBT) should be implemented alongside medication, as recommended by the American Academy of Child and Adolescent Psychiatry 1, 2

Medication Management

  • For patients with severe, persistent anger and aggression, a mood stabilizer such as divalproex sodium or lithium should be considered as first-line treatment, with atypical antipsychotics like risperidone reserved for more severe cases or when mood stabilizers are ineffective 1
  • Risperidone has demonstrated effectiveness for managing irritability and aggression in youth, with positive findings typically starting within 2 weeks of initiation, at doses around 1.16-2.9 mg/day in most studies 3
  • Divalproex sodium shows significant efficacy for mood lability and explosive temper, with a starting dose of 125 mg twice daily and a target therapeutic blood level of 40-90 mcg/mL, resulting in a 70% reduction in aggression scores after 6 weeks of treatment 4
  • Lithium is effective for aggression in various populations, with dosing titrated to therapeutic blood levels (0.6-1.4 mEq/L), and is a first-line choice for patients with bipolar features 5
  • Aripiprazole is an alternative option, with dosing of 5-15 mg/day for adolescents 6

Behavioral Interventions

  • Anger management groups with daily practice sessions, social skills training emphasizing safe boundaries and handling frustration, and family involvement in supporting skills practice are recommended, as suggested by the American Academy of Child and Adolescent Psychiatry 2
  • Cognitive behavioral therapy (CBT) is recommended to be implemented alongside medication, particularly anger management and stress reduction techniques, according to the American Academy of Child and Adolescent Psychiatry 2

Special Considerations

  • For patients with ADHD, stimulants may help reduce aggression when it occurs in the context of ADHD 3
  • For patients with psychosis, atypical antipsychotics are first-line 4
  • For patients with bipolar features, lithium is preferred 5
  • For patients with seizure disorder/abnormal EEG, anticonvulsants are treatment of choice 4

Monitoring and Side Effects

  • Monitor weight, BMI, lipids, and glucose regularly, and watch for extrapyramidal symptoms, sedation, and prolactin elevation 3, 6
  • Common side effects of risperidone include somnolence, headache, weight gain, and increased prolactin levels, highlighting the need for careful monitoring 3
  • For mood stabilizers, regular blood level monitoring is necessary, as well as monitoring renal and thyroid function with lithium, and liver function and platelets with divalproex 6

Treatment Approach

  • The initial medication selection should consider underlying diagnoses, with divalproex sodium or lithium as the first choice for most patients, and risperidone for severe, persistent aggression 4, 5
  • For mild-moderate symptoms, start with a mood stabilizer, while for severe symptoms with acute danger, consider an atypical antipsychotic 4
  • If there is an inadequate response to initial treatment, add a second medication, combining a mood stabilizer with an atypical antipsychotic 4
  • For treatment-resistant cases, consider combination therapy with a mood stabilizer plus an atypical antipsychotic, or alternative atypical antipsychotics if the first choice is ineffective 4, 6
  • Avoid polypharmacy when possible, but recognize that combination therapy is often necessary for severe cases 5

Acute Agitation Management

  • Benzodiazepines (lorazepam, midazolam) or conventional antipsychotics are effective for acute agitation, with a combination of oral benzodiazepine and antipsychotic recommended for cooperative patients 7
  • Offer oral medication before considering intramuscular injections for chemical restraint in acute situations, as suggested by guidelines 2